Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Mathias Leys
AZ Groeninge
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
26
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Rapid & sustained benefit of benralizumab in severe eosinophilic asthma: the BE-REAL study
Number of pages: 35
Posted: 17 Mar 2026
Lieven Dupont
,
Charles Pilette
,
Maud Deschampheleire
,
Katrien Eger
,
Jean-Benoît Martinot
, Mathias Leys,
Ulrike Himpe
,
Rudi Peché
,
Muriel Lins
,
Solange Delovinfosse
,
Hélène Simonis
,
An Herreman
,
Leen Janssen
,
Charlotte Quataert
,
Tom Feys
and
Renaud Louis
Department of Respiratory Medicine, Ghent University Hospital,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Clinique Sainte-Elisabeth, AZ Groeninge,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, AZ Sint-Maarten - Pneumology General Hospital Sint-Maarten,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
and
affiliation not provided to SSRN
Downloads
26
(1,411,822)
View PDF
Download
Abstract:
Asthma, SEA, benralizumab, real-world data, Belgium, clinical remission, asthma control, ACQ6
Feedback